Drug profile · INN
moxalactam disodium
MOXAM
moxalactam disodium (MOXAM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — moxalactam disodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
moxalactam disodium (MOXAM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is moxalactam disodium?
moxalactam disodium (MOXAM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for moxalactam disodium?
MOXAM is a marketed brand name for moxalactam disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of moxalactam disodium?
moxalactam disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.